panitumumab,bevacizumab
takeda,roche,amgen
['cairo5', 'crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)']
cairo5 unresectable crlm left sided/ras/braf wt no difference in primary pfs endpoint #crc #esmo22 
Research Fellow @myESMO @TheChristieNHS #CPOClab | Medical Oncologist @COBLH | PhD candidate @syd_health @GarvanInstitute | Traveller, Hiker | Opinions my own